Are these tests a choice that is wise?
A decade ago, companies began developing saliva-based, at-home hereditary tests that provide people the capacity to find out about their genetic characteristics. These tests began with ancestry information, then developed to add faculties (such as hair loss and locks color), predispositions for health issues (such as for example Parkinson’s disease and cancer of the breast), and reactions to prescription that is certain. These “direct-to-consumer” (DTC) tests provide fast, affordable hereditary screening without needing to consult with a physician… But is it a very wise choice? And exactly how if the total outcomes be interpreted and utilized?
Know the restrictions: mail-order tests are neither comprehensive nor definitive
In March 2018, the United States Food and Drug management authorized DTC company 23andMe to report on dangers pertaining to the BRCA2 and BRCA1 genes. (mais…)
Comentários